GlassScriptPhysician profile
Giuseppe Palermo
NPI 1962507863
$59,058.78
in general payments reported to CMS, 2019-2025
98 companies · $9,872 in 2025
The $9,872 reported for 2025 was more than what 81% of Medical Oncology providers received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,265 · 2020: $4,800 · 2021: $7,367 · 2022: $7,691 · 2023: $8,586 · 2024: $11K · 2025: $9,872.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $29K · Education: $1,101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $28,835.25 |
| Education | $1,101.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $4,965.70 | 2019-2025 | Enhertu, Imfinzi, Lynparza |
| Janssen Biotech, INC. | $3,973.58 | 2019-2025 | Rybrevant, Darzalex, Carvykti |
| Pharmacyclics LLC, An Abbvie Company | $3,540.91 | 2019-2023 | Imbruvica |
| E.R. Squibb & Sons, L.L.C. | $3,068.05 | 2019-2025 | Opdivo, Reblozyl, Abecma |
| Pfizer INC. | $2,386.22 | 2019-2025 | |
| Incyte Corporation | $2,300.40 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Merck Sharp & Dohme LLC | $2,207.26 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Amgen INC. | $2,165.13 | 2019-2025 | Kyprolis, Lumakras, Nplate |
| Novartis Pharmaceuticals Corporation | $1,866.37 | 2019-2025 | Piqray, Kisqali |
| Genentech USA, INC. | $1,798.59 | 2019-2025 | Lunsumio, Polivy, Tecentriq |
| Seagen INC. | $1,761.70 | 2019-2025 | Adcetris, Padcev, Tivdak |
| Genzyme Corporation | $1,745.45 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $1,544.81 | 2019-2025 | Fruzaqla, Iclusig, Alunbrig |
| Regeneron Healthcare Solutions, INC. | $1,527.00 | 2019-2025 | Libtayo |
| Lilly USA, LLC | $1,409.96 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
Show all 98 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $1,387.39 | 2019-2025 | Enhertu, Vanflyta |
| Astellas Pharma US INC | $1,320.26 | 2019-2025 | Vyloy, Xtandi, Padcev |
| Glaxosmithkline, LLC. | $1,296.29 | 2020-2025 | Ojjaara, Zejula, Jemperli |
| Bayer Healthcare Pharmaceuticals INC. | $1,201.21 | 2019-2025 | |
| Eisai INC. | $1,170.71 | 2019-2025 | |
| Celgene Corporation | $992.11 | 2019-2025 | Reblozyl, Pomalyst |
| Abbvie INC. | $984.97 | 2019-2025 | |
| Jazz Pharmaceuticals INC. | $885.68 | 2020-2025 | Zepzelca |
| Gilead Sciences, INC. | $710.38 | 2019-2025 | Trodelvy |
| Beigene USA, INC. | $666.17 | 2020-2025 | Brukinsa, Tevimbra |
| Kite Pharma, INC. | $618.57 | 2020-2025 | Yescarta |
| Ipsen Biopharmaceuticals, INC | $506.93 | 2019-2025 | Tazverik, Onivyde, Somatuline Depot |
| Blueprint Medicines Corporation | $503.10 | 2021-2025 | Ayvakit |
| Exelixis INC. | $501.90 | 2019-2025 | Cabometyx |
| Karyopharm Therapeutics INC. | $494.79 | 2020-2025 | Xpovio |
| Emd Serono, INC. | $493.10 | 2020-2025 | Bavencio |
| Puma Biotechnology, INC. | $480.36 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $407.20 | 2019-2025 | Ultomiris, Soliris |
| Mirati Therapeutics, INC. | $364.34 | 2023-2024 | Krazati |
| Servier Pharmaceuticals LLC | $360.26 | 2022-2025 | |
| Pharmacosmos Therapeutics INC. | $349.86 | 2020-2025 | Monoferric, Cosela |
| Novocure INC. | $344.68 | 2019-2025 | Optune, Optune Lua (Novottf-200t) |
| Genmab U.S., INC. | $343.20 | 2023-2025 | Epkinly |
| Sobi, INC | $337.01 | 2023-2025 | |
| Coherus Oncology, INC. | $329.79 | 2022-2025 | Loqtorzi |
| Taiho Oncology, INC. | $316.90 | 2019-2024 | |
| Dendreon Pharmaceuticals LLC | $272.63 | 2024-2025 | Provenge |
| G1 Therapeutics, INC. | $259.78 | 2021-2023 | Cosela |
| Pharmaessentia USA Corporation | $259.48 | 2024-2025 | Besremi |
| Array Biopharma INC | $248.55 | 2020-2025 | Braftovi, Mektovi, Lorbrena |
| Boehringer Ingelheim Pharmaceuticals, INC. | $248.29 | 2019-2025 | |
| Rigel Pharmaceuticals, INC. | $218.15 | 2019-2024 | Tavalisse, Rezlidhia |
| Recordati_rare_diseases_inc. | $212.27 | 2023-2025 | Sylvant, Enjaymo |
| Myovant Sciences INC. | $204.42 | 2021-2022 | |
| Geron Corporation | $193.00 | 2024-2025 | Rytelo |
| Sumitomo Pharma America, INC. | $186.60 | 2023-2025 | Orgovyx |
| Sanofi-Aventis U.S. LLC | $184.74 | 2019-2023 | |
| Adc Therapeutics America, INC. | $169.60 | 2022-2025 | |
| Stemline Therapeutics INC. | $166.23 | 2023-2025 | Orserdu |
| Verastem, INC. | $156.48 | 2019 | |
| Aveo Pharmaceuticals, INC. | $148.75 | 2023-2024 | Fotivda |
| Advanced Accelerator Applications | $145.65 | 2019-2020 | |
| Syndax Pharmaceuticals, INC. | $142.33 | 2025 | |
| Dova Pharmaceuticals | $141.81 | 2020-2021 | |
| Epizyme, INC. | $141.33 | 2020 | |
| Eusa Pharma (US) LLC | $141.19 | 2019 | |
| Celltrion USA INC. | $118.61 | 2023 | Vegzelma |
| Immunomedics, INC. | $114.47 | 2020 | |
| Agios Pharmaceuticals, INC. | $111.96 | 2020-2025 | Pyrukynd |
| Deciphera Pharmaceuticals INC. | $110.61 | 2021-2025 | Qinlock, Romvimza |
| Heron Therapeutics, INC. | $96.50 | 2019-2022 | |
| Clovis Oncology, INC. | $78.10 | 2019-2021 | |
| Beone Medicines USA, INC. | $76.08 | 2025 | Brukinsa, Tevimbra |
| Fennec Pharmaceuticals, INC. | $67.85 | 2024-2025 | Pedmark, Fyarro |
| Iovance Biotherapeutics, INC. | $60.96 | 2024-2025 | Amtagvi |
| Tersera Therapeutics LLC | $57.49 | 2025 | Zoladex |
| Global Blood Therapeutics, INC. | $47.39 | 2020-2022 | |
| Tg Therapeutics, INC. | $46.79 | 2021 | |
| Morphosys, US INC. | $46.01 | 2022-2024 | Monjuvi |
| Immunocore Limited | $42.58 | 2025 | Kimmtrak |
| Tesaro, INC. | $39.80 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $38.82 | 2019 | |
| Caris Mpi, INC. | $36.99 | 2025 | Mi Cancer Seek |
| Acceleron Pharma, INC. | $36.47 | 2020-2021 | |
| Springworks Therapeutics, INC. | $35.92 | 2025 | Gomekli, Ogsiveo |
| Biocon Biologics INC | $24.63 | 2024 | Fulphila |
| Alnylam Pharmaceuticals INC. | $23.89 | 2023 | Givlaari |
| Sun Pharmaceutical Industries INC. | $22.32 | 2022 | |
| Menarini Silicon Biosystems, INC. | $21.87 | 2024 | |
| Secura Bio, INC. | $21.80 | 2019-2020 | |
| Mylan Institutional INC. | $21.63 | 2021 | |
| Nuvation Bio INC. | $18.24 | 2025 | Ibtrozi |
| Accord Healthcare, INC. | $17.77 | 2025 | |
| Amag Pharmaceuticals, INC. | $16.97 | 2022 | |
| Partner Therapeutics, INC. | $16.79 | 2020 | |
| Pharmaand Gmbh | $16.38 | 2025 | Rubraca |
| Tolmar, INC. | $16.38 | 2025 | Eligard, Rubraca |
| Helsinn Therapeutics (U.S.), INC. | $16.16 | 2019 | |
| Amneal Pharmaceuticals LLC | $16.04 | 2025 | Alymsys |
| Verity Pharmaceuticals INC. | $14.54 | 2025 | Trelstar |
| Macrogenics, INC. | $14.31 | 2023 | |
| Azurity Pharmaceuticals, INC. | $13.90 | 2024 | Vivimusta |
| Janssen Pharmaceuticals, INC | $12.19 | 2019-2021 |
Drugs and devices associated with these payments
Enhertu $1,553Rybrevant $1,205Keytruda $1,203Libtayo $910Darzalex $802Carvykti $798Opdivo $775Jakafi $755Tecvayli $716Sarclisa $624Xtandi $622Reblozyl $621Lynparza $620Adcetris $560Epkinly $522Orgovyx $502Ojjaara $490Lenvima $484Verzenio $483Jaypirca $482Brukinsa $446Nubeqa $437Fruzaqla $398Zepzelca $396Trodelvy $367Krazati $364Monjuvi $330Imfinzi $328Kisqali $322Talzenna $321Imbruvica $316Retevmo $302Elrexfio $281Provenge $273Vyloy $270Tukysa $263Kyprolis $261Besremi $259Monoferric $250Tagrisso $247Ayvakit $241Calquence $241Talvey $237Padcev $236Lorbrena $224Zejula $218Lunsumio $218Erleada $210Elahere $207Xpovio $204Venclexta $197Vonjo $196Lonsurf $194Rytelo $193Akeega $193Yescarta $191Welireg $184Pemazyre $181Braftovi $181Mektovi $181Tazverik $174Orserdu $166Pomalyst $165Ultomiris $165Cablivi $163Loqtorzi $159Optune $158Jemperli $157Lumakras $154Sylvant $152Elitek $150Fotivda $149Tivdak $148Voranigo $147Cosela $145Tibsovo $144Nplate $142Doptelet $141Ibrance $140Blincyto $139Ziihera $132Iclusig $128Abecma $125Datroway $125Augtyro $124Bosulif $124Comirnaty $122Vitrakvi $120Stivarga $120Vegzelma $119Rezlidhia $115Tavalisse $115Paxlovid $102Fabhalta $102Piqray $98.52Pluvicto $94.20Enjaymo $93.26Cabometyx $91.56Tevimbra $87.17Alunbrig $86.93
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Giuseppe Palermo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.